172 related articles for article (PubMed ID: 24532410)
1. In vivo ³¹P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts.
Esmaeili M; Moestue SA; Hamans BC; Veltien A; Kristian A; Engebråten O; Maelandsmo GM; Gribbestad IS; Bathen TF; Heerschap A
J Magn Reson Imaging; 2015 Mar; 41(3):601-9. PubMed ID: 24532410
[TBL] [Abstract][Full Text] [Related]
2. Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.
Esmaeili M; Bathen TF; Engebråten O; Mælandsmo GM; Gribbestad IS; Moestue SA
Magn Reson Med; 2014 Jun; 71(6):1973-81. PubMed ID: 23878023
[TBL] [Abstract][Full Text] [Related]
3. Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models.
Moestue SA; Borgan E; Huuse EM; Lindholm EM; Sitter B; Børresen-Dale AL; Engebraaten O; Maelandsmo GM; Gribbestad IS
BMC Cancer; 2010 Aug; 10():433. PubMed ID: 20716336
[TBL] [Abstract][Full Text] [Related]
4. Phosphorus magnetic resonance spectroscopic imaging at 7 T in patients with prostate cancer.
Lagemaat MW; Vos EK; Maas MC; Bitz AK; Orzada S; van Uden MJ; Kobus T; Heerschap A; Scheenen TW
Invest Radiol; 2014 May; 49(5):363-72. PubMed ID: 24335715
[TBL] [Abstract][Full Text] [Related]
5. Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.
Grinde MT; Skrbo N; Moestue SA; Rødland EA; Borgan E; Kristian A; Sitter B; Bathen TF; Børresen-Dale AL; Mælandsmo GM; Engebraaten O; Sørlie T; Marangoni E; Gribbestad IS
Breast Cancer Res; 2014 Jan; 16(1):R5. PubMed ID: 24447408
[TBL] [Abstract][Full Text] [Related]
6. 31P MRSI and 1H MRS at 7 T: initial results in human breast cancer.
Klomp DW; van de Bank BL; Raaijmakers A; Korteweg MA; Possanzini C; Boer VO; van de Berg CA; van de Bosch MA; Luijten PR
NMR Biomed; 2011 Dec; 24(10):1337-42. PubMed ID: 21433156
[TBL] [Abstract][Full Text] [Related]
7. Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts.
Morse DL; Raghunand N; Sadarangani P; Murthi S; Job C; Day S; Howison C; Gillies RJ
Magn Reson Med; 2007 Aug; 58(2):270-80. PubMed ID: 17654590
[TBL] [Abstract][Full Text] [Related]
8. 31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.
Komoroski RA; Holder JC; Pappas AA; Finkbeiner AE
Magn Reson Med; 2011 Apr; 65(4):911-3. PubMed ID: 20967792
[TBL] [Abstract][Full Text] [Related]
9. (31) P MR spectroscopic imaging combined with (1) H MR spectroscopic imaging in the human prostate using a double tuned endorectal coil at 7T.
Luttje MP; Italiaander MG; Arteaga de Castro CS; van der Kemp WJ; Luijten PR; van Vulpen M; van der Heide UA; Klomp DW
Magn Reson Med; 2014 Dec; 72(6):1516-21. PubMed ID: 24357271
[TBL] [Abstract][Full Text] [Related]
10. Early detection of changes in phospholipid metabolism during neoadjuvant chemotherapy in breast cancer patients using phosphorus magnetic resonance spectroscopy at 7T.
Krikken E; van der Kemp WJM; van Diest PJ; van Dalen T; van Laarhoven HWM; Luijten PR; Klomp DWJ; Wijnen JP
NMR Biomed; 2019 Jun; 32(6):e4086. PubMed ID: 30924571
[TBL] [Abstract][Full Text] [Related]
11. Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS.
Wijnen JP; Jiang L; Greenwood TR; Cheng M; Döpkens M; Cao MD; Bhujwalla ZM; Krishnamachary B; Klomp DW; Glunde K
NMR Biomed; 2014 Jun; 27(6):692-9. PubMed ID: 24764256
[TBL] [Abstract][Full Text] [Related]
12. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
Glunde K; Jie C; Bhujwalla ZM
Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions.
Gruber S; Debski BK; Pinker K; Chmelik M; Grabner G; Helbich T; Trattnig S; Bogner W
Radiology; 2011 Dec; 261(3):752-61. PubMed ID: 21998046
[TBL] [Abstract][Full Text] [Related]
14. Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling.
Cao MD; Sitter B; Bathen TF; Bofin A; Lønning PE; Lundgren S; Gribbestad IS
NMR Biomed; 2012 Feb; 25(2):369-78. PubMed ID: 21823183
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study.
Jacobs MA; Barker PB; Bottomley PA; Bhujwalla Z; Bluemke DA
J Magn Reson Imaging; 2004 Jan; 19(1):68-75. PubMed ID: 14696222
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of breast cancer using proton MR spectroscopy: total choline peak integral and signal-to-noise ratio as prognostic indicators.
Shin HJ; Baek HM; Cha JH; Kim HH
AJR Am J Roentgenol; 2012 May; 198(5):W488-97. PubMed ID: 22528931
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.
Al-Saffar NM; Troy H; Ramírez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL
Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258
[TBL] [Abstract][Full Text] [Related]
18. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence.
Chen AP; Cunningham CH; Kurhanewicz J; Xu D; Hurd RE; Pauly JM; Carvajal L; Karpodinis K; Vigneron DB
Magn Reson Imaging; 2006 Sep; 24(7):825-32. PubMed ID: 16916699
[TBL] [Abstract][Full Text] [Related]
19. Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy.
Valentini AL; Gui B; D'Agostino GR; Mattiucci G; Clementi V; Di Molfetta IV; Bonomo P; Mantini G
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):719-24. PubMed ID: 22436789
[TBL] [Abstract][Full Text] [Related]
20. 31P magnetic resonance spectroscopic imaging with polarisation transfer of phosphomono- and diesters at 3 T in the human brain: relation with age and spatial differences.
Wijnen JP; Scheenen TW; Klomp DW; Heerschap A
NMR Biomed; 2010 Oct; 23(8):968-76. PubMed ID: 20669234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
